Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04400474
Title Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications

gastrointestinal neuroendocrine tumor

pulmonary neuroendocrine tumor

paraganglioma

pheochromocytoma

neuroendocrine carcinoma

thyroid gland anaplastic carcinoma

neuroendocrine tumor

adrenocortical carcinoma

Therapies

Atezolizumab + Cabozantinib

Age Groups: senior | adult
Covered Countries


No variant requirements are available.